Possibly, a beneficial proportion between the different levels of potency of proxalutamide when acting as an anti-androgen, ACE-2 regulator, and as an anti-inflammatory may justify its efficacy for COVID-19 throughout different stages of the disease. This evidence concerns the gene ACE2 and COVID-19.